AXA Assistance .:: Panama ::. Diabetes Disease Management Program Formulary

Some Diabetes related drugs below have more information available:

Below is a summary of the most important statistics of the Diabetes disease management program:

PARAMETER	ABSOLUTE VALUE	%
Total number of patients in the program	2590	100
Deaths	54	2.08
Patients with HbA1C evaluation	2145	82.82
Total number of HbA1c evaluations	3542
HbA1C evaluations ≤ 7%	2017	56.95
Patients with 1 HbA1C evaluation ≤ 7%	845	39.39
Patients with 2 HbA1C evaluation ≤ 7%	418	19.49
Patients with 3 HbA1C evaluation ≤ 7%	100	4.66
Patients with 4 HbA1C evaluation ≤ 7%	9	0.42
Patients with LDL evaluation	1074	41.47
Patients with LDL evaluation < 130	862	80.26
Patients with LDL evaluation < 100	568	52.89
Patients with HDL evaluation	1050	40.54
Patients with HDL evaluation > 40	742	70.67
Patients with TG evaluation	1115	43.05
Patients with TG evaluation < 150	809	72.56

Patients with Microalbuminuria evaluation	47	1.81
Patients with positive Microalbuminuria	14	29.79
Patients with negative Microalbuminuria	33	70.21

HbA1C = Glycosylated hemoglobin
LDL = low-density lipoprotein
HDL = high-density lipoprotein
TG = triglycerides

* This information is only for the POS members of the plan, FFS members are not eligible for this benefit.